Drug
Odm103
Odm103: highest development phase Phase 1, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| ODM103 NCT01688089 | Phase 1 | Healthy |
Latest
No recent events.
Follow Odm103 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.